{{Distinguish | propanol | propofol | propranolol}}

{{Drugbox
| IUPAC_name = 3-(1-methyl-3-propyl-pyrrolidin-3-yl)phenol
| image = Profadol skeletal.svg
| width = 200px

<!--Clinical data-->
| tradename =
| pregnancy_category =
| legal_US = analogue
| legal_US_comment = (Analogue of [[Tapentadol]], Schedule II)
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number = 428-37-5
| ATC_prefix = none
| ATC_suffix =
| PubChem = 9882
| DrugBank =
| ChEMBL = 161204
| ChemSpiderID = 9498
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 41GDG43FTT

<!--Chemical data-->
| C=14 | H=21 | N=1 | O=1 
| molecular_weight = 219.32 g/mol
}}

'''Profadol''' (CI-572) is an [[opioid]] [[analgesic]] which was developed in the 1960s by Parke-Davis.<ref>DE Patent 1303096</ref> It acts as a mixed [[agonist]]-[[receptor antagonist|antagonist]] of the [[mu-opioid receptor|μ-opioid receptor]]. The analgetic potency is about the same as of [[pethidine]] (meperidine), the antagonistic effect is 1/50 of [[nalorphine]].<ref>Eberhard Schröder, Clemens Rufer, Ralph Schmiechen, Arzneimittelchemie I, Georg Thieme Verlag 1976 {{ISBN|3-13-520601-7}}</ref>

== See also ==
{{colbegin||12em}}
* [[BDPC|Bromadol]]
* [[C-8813]]
* [[Ciramadol]]
* [[Faxeladol]]
* [[Prodilidine]]
* [[Tapentadol]]
* [[Tramadol]]
{{colend}}

== References ==
{{Reflist|2}}

{{Analgesics}}
{{Opioidergics}}

[[Category:Phenols]]
[[Category:Pyrrolidines]]